<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">63294</article-id><article-id pub-id-type="doi">10.7554/eLife.63294</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Tools and Resources</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Introduction to the EQIPD quality system</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-131754"><name><surname>Bespalov</surname><given-names>Anton</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3730-1395</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-151261"><name><surname>Bernard</surname><given-names>René</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3265-2372</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210285"><name><surname>Gilis</surname><given-names>Anja</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-204807"><name><surname>Gerlach</surname><given-names>Björn</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4900-6302</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-210286"><name><surname>Guillen</surname><given-names>Javier</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8188-7587</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-210287"><name><surname>Castagne</surname><given-names>Vincent</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-210288"><name><surname>Lefevre</surname><given-names>Isabel</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf7"/></contrib><contrib contrib-type="author" id="author-210289"><name><surname>Ducrey</surname><given-names>Fiona</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf8"/></contrib><contrib contrib-type="author" id="author-210290"><name><surname>Monk</surname><given-names>Lee</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf9"/></contrib><contrib contrib-type="author" id="author-210291"><name><surname>Bongiovanni</surname><given-names>Sandrine</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8655-6514</contrib-id><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="conf10"/></contrib><contrib contrib-type="author" id="author-210292"><name><surname>Altevogt</surname><given-names>Bruce</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="conf11"/></contrib><contrib contrib-type="author" id="author-210293"><name><surname>Arroyo Araujo</surname><given-names>Maria</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210294"><name><surname>Bikovski</surname><given-names>Lior</given-names></name><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210295"><name><surname>de Bruin</surname><given-names>Natasja</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2456-2783</contrib-id><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210296"><name><surname>Castaños-Vélez</surname><given-names>Esmeralda</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2670-1118</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42774"><name><surname>Dityatev</surname><given-names>Alexander</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0472-0553</contrib-id><xref ref-type="aff" rid="aff15">15</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210297"><name><surname>Emmerich</surname><given-names>Christoph H</given-names></name><xref ref-type="aff" rid="aff16">16</xref><xref ref-type="fn" rid="conf12"/></contrib><contrib contrib-type="author" id="author-210298"><name><surname>Fares</surname><given-names>Raafat</given-names></name><xref ref-type="aff" rid="aff17">17</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210299"><name><surname>Ferland-Beckham</surname><given-names>Chantelle</given-names></name><xref ref-type="aff" rid="aff18">18</xref><xref ref-type="fn" rid="conf13"/></contrib><contrib contrib-type="author" id="author-210304"><name><surname>Froger-Colléaux</surname><given-names>Christelle</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf14"/></contrib><contrib contrib-type="author" id="author-56442"><name><surname>Gailus-Durner</surname><given-names>Valerie</given-names></name><xref ref-type="aff" rid="aff19">19</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-56440"><name><surname>Hölter</surname><given-names>Sabine M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4878-5241</contrib-id><xref ref-type="aff" rid="aff20">20</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210305"><name><surname>Hofmann</surname><given-names>Martine CJ</given-names></name><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210306"><name><surname>Kabitzke</surname><given-names>Patricia</given-names></name><xref ref-type="aff" rid="aff21">21</xref><xref ref-type="fn" rid="conf15"/></contrib><contrib contrib-type="author" id="author-86885"><name><surname>Kas</surname><given-names>Martien J H</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4471-8618</contrib-id><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210307"><name><surname>Kurreck</surname><given-names>Claudia</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf16"/></contrib><contrib contrib-type="author" id="author-210308"><name><surname>Moser</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="aff22">22</xref><xref ref-type="fn" rid="conf17"/></contrib><contrib contrib-type="author" id="author-210309"><name><surname>Pietraszek</surname><given-names>Malgorzata</given-names></name><xref ref-type="aff" rid="aff16">16</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210310"><name><surname>Popik</surname><given-names>Piotr</given-names></name><xref ref-type="aff" rid="aff23">23</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-39242"><name><surname>Potschka</surname><given-names>Heidrun</given-names></name><xref ref-type="aff" rid="aff24">24</xref><xref ref-type="fn" rid="conf18"/></contrib><contrib contrib-type="author" id="author-210312"><name><surname>Prado Montes de Oca</surname><given-names>Ernesto</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0617-4752</contrib-id><xref ref-type="aff" rid="aff25">25</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-169099"><name><surname>Restivo</surname><given-names>Leonardo</given-names></name><xref ref-type="aff" rid="aff26">26</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210313"><name><surname>Riedel</surname><given-names>Gernot</given-names></name><xref ref-type="aff" rid="aff27">27</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-178424"><name><surname>Ritskes-Hoitinga</surname><given-names>Merel</given-names></name><xref ref-type="aff" rid="aff28">28</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210314"><name><surname>Samardzic</surname><given-names>Janko</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8464-4924</contrib-id><xref ref-type="aff" rid="aff29">29</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210315"><name><surname>Schunn</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff30">30</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210316"><name><surname>Stöger</surname><given-names>Claudia</given-names></name><xref ref-type="aff" rid="aff31">31</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210317"><name><surname>Voikar</surname><given-names>Vootele</given-names></name><xref ref-type="aff" rid="aff32">32</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210318"><name><surname>Vollert</surname><given-names>Jan</given-names></name><xref ref-type="aff" rid="aff33">33</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-60667"><name><surname>Wever</surname><given-names>Kimberley E</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3635-3660</contrib-id><xref ref-type="aff" rid="aff28">28</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210319"><name><surname>Wuyts</surname><given-names>Kathleen</given-names></name><xref ref-type="aff" rid="aff34">34</xref><xref ref-type="fn" rid="conf19"/></contrib><contrib contrib-type="author" id="author-59124"><name><surname>MacLeod</surname><given-names>Malcolm R</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9187-9839</contrib-id><xref ref-type="aff" rid="aff35">35</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf20"/></contrib><contrib contrib-type="author" id="author-210320"><name><surname>Dirnagl</surname><given-names>Ulrich</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0755-6119</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf21"/></contrib><contrib contrib-type="author" id="author-210321"><name><surname>Steckler</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf22"/></contrib><aff id="aff1"><institution content-type="dept">none</institution>, <institution>PAASP</institution>, <addr-line><named-content content-type="city">Heidelberg</named-content></addr-line>, <country>Germany</country></aff><aff id="aff2"><institution>Charité Universitätsmedizin</institution>, <addr-line><named-content content-type="city">Berlin</named-content></addr-line>, <country>Germany</country></aff><aff id="aff3"><institution content-type="dept">Janssen Pharmaceutica NV</institution>, <institution>Janssen Pharmaceutica NV</institution>, <addr-line><named-content content-type="city">Beerse</named-content></addr-line>, <country>Belgium</country></aff><aff id="aff4"><institution content-type="dept">Operational</institution>, <institution>PAASP GmbH</institution>, <addr-line><named-content content-type="city">Heidelberg</named-content></addr-line>, <country>Germany</country></aff><aff id="aff5"><institution content-type="dept">AAALAC International</institution>, <institution>AAALAC International</institution>, <addr-line><named-content content-type="city">Pamplona</named-content></addr-line>, <country>Spain</country></aff><aff id="aff6"><institution content-type="dept">Porsolt</institution>, <institution>Porsolt</institution>, <addr-line><named-content content-type="city">Le Genest-Saint-Isle</named-content></addr-line>, <country>France</country></aff><aff id="aff7"><institution content-type="dept">Rare and Neurologic Diseases Research</institution>, <institution>Sanofi</institution>, <addr-line><named-content content-type="city">Chilly-Mazarin</named-content></addr-line>, <country>France</country></aff><aff id="aff8"><institution content-type="dept">Integrity and Global Research Practices</institution>, <institution>Sanofi</institution>, <addr-line><named-content content-type="city">Chilly-Mazarin</named-content></addr-line>, <country>France</country></aff><aff id="aff9"><institution content-type="dept">Research and Clinical Development Quality</institution>, <institution>UCB</institution>, <addr-line><named-content content-type="city">Slough</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff10"><institution content-type="dept">Quality Assurance, Novartis Institutes for BioMedical Research</institution>, <institution>Novartis pharma</institution>, <addr-line><named-content content-type="city">Basel</named-content></addr-line>, <country>Switzerland</country></aff><aff id="aff11"><institution content-type="dept">Pfizer</institution>, <institution>Pfizer</institution>, <addr-line><named-content content-type="city">Silver Spring</named-content></addr-line>, <country>United States</country></aff><aff id="aff12"><institution content-type="dept">Groningen Institute for Evolutionary Life Sciences</institution>, <institution>University of Groningen</institution>, <addr-line><named-content content-type="city">Groningen</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff13"><institution content-type="dept">The Myers Neuro-Behavioral Core Facility, Sackler School of Medicine</institution>, <institution>Tel Aviv University</institution>, <addr-line><named-content content-type="city">Tel Aviv</named-content></addr-line>, <country>Israel</country></aff><aff id="aff14"><institution content-type="dept">Branch for Translational Medicine and Pharmacology TMP</institution>, <institution>Fraunhofer Institute for Molecular Biology and Applied Ecology IME</institution>, <addr-line><named-content content-type="city">Frankfurt</named-content></addr-line>, <country>Germany</country></aff><aff id="aff15"><institution content-type="dept">Molecular Neuroplasticity Group</institution>, <institution>Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)</institution>, <addr-line><named-content content-type="city">Magdeburg</named-content></addr-line>, <country>Germany</country></aff><aff id="aff16"><institution content-type="dept">PAASP</institution>, <institution>PAASP</institution>, <addr-line><named-content content-type="city">Heidelberg</named-content></addr-line>, <country>Germany</country></aff><aff id="aff17"><institution content-type="dept">Safety Assessment</institution>, <institution>Charles River Laboratories</institution>, <addr-line><named-content content-type="city">Lyon</named-content></addr-line>, <country>France</country></aff><aff id="aff18"><institution content-type="dept">Cohen Veterans Bioscience</institution>, <institution>Cohen Veterans Bioscience</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff19"><institution content-type="dept">Institute of Experimental Genetics</institution>, <institution>German Mouse Clinic</institution>, <addr-line><named-content content-type="city">München</named-content></addr-line>, <country>Germany</country></aff><aff id="aff20"><institution content-type="dept">Institute of Developmental Genetics</institution>, <institution>Helmholtz Zentrum München</institution>, <addr-line><named-content content-type="city">Neuherberg</named-content></addr-line>, <country>Germany</country></aff><aff id="aff21"><institution content-type="dept">The Stanley Center for Psychiatric Research</institution>, <institution>Broad Institute of MIT &amp; Harvard</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><aff id="aff22"><institution content-type="dept">PAASP</institution>, <institution>PAASP</institution>, <addr-line><named-content content-type="city">Toulouse</named-content></addr-line>, <country>France</country></aff><aff id="aff23"><institution content-type="dept">Maj Institute of Pharmacology</institution>, <institution>Polish Academy of Sciences</institution>, <addr-line><named-content content-type="city">Krakow</named-content></addr-line>, <country>Poland</country></aff><aff id="aff24"><institution content-type="dept">Department of veterinary medicine of the Ludwig-Maximilians-University</institution>, <institution>Institute of Pharmacology, Toxicology, and Pharmacy</institution>, <addr-line><named-content content-type="city">Munich</named-content></addr-line>, <country>Germany</country></aff><aff id="aff25"><institution content-type="dept">Research Center in Technology and Design Assistance of Jalisco State</institution>, <institution>National Council of Science and Technology</institution>, <addr-line><named-content content-type="city">Guadalajara</named-content></addr-line>, <country>Mexico</country></aff><aff id="aff26"><institution content-type="dept">Fundamental Neuroscience</institution>, <institution>The University of Lausanne</institution>, <addr-line><named-content content-type="city">Lausanne</named-content></addr-line>, <country>Switzerland</country></aff><aff id="aff27"><institution content-type="dept">Institute of Medical Sciences</institution>, <institution>University of Aberdeen</institution>, <addr-line><named-content content-type="city">Aberdeen</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff28"><institution>Radboud University Medical Center</institution>, <addr-line><named-content content-type="city">Nijmegen</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff29"><institution content-type="dept">Institute of Pharmacology, Medical Faculty</institution>, <institution>University of Belgrade</institution>, <addr-line><named-content content-type="city">Belgrade</named-content></addr-line>, <country>Serbia</country></aff><aff id="aff30"><institution content-type="dept">Institute of Science and Technology</institution>, <institution>Institute of Science and Technology</institution>, <addr-line><named-content content-type="city">Klosterneuburg</named-content></addr-line>, <country>Austria</country></aff><aff id="aff31"><institution content-type="dept">German Mouse Clinic, Institute of Experimental Genetics</institution>, <institution>Helmholtz Zentrum München</institution>, <addr-line><named-content content-type="city">Munich</named-content></addr-line>, <country>Germany</country></aff><aff id="aff32"><institution content-type="dept">Neuroscience Center and Laboratory Animal Center, Helsinki Institute of Life Science</institution>, <institution>University of Helsinki</institution>, <addr-line><named-content content-type="city">Helsinki</named-content></addr-line>, <country>Finland</country></aff><aff id="aff33"><institution content-type="dept">Pain Research, Department of Surgery and Cancer, Faculty of Medicine</institution>, <institution>Imperial College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff34"><institution content-type="dept">Avertim</institution>, <institution>Avertim</institution>, <addr-line><named-content content-type="city">Brussels</named-content></addr-line>, <country>Belgium</country></aff><aff id="aff35"><institution content-type="dept">Centre for Clinical Brain Sciences</institution>, <institution>University of Edinburgh</institution>, <addr-line><named-content content-type="city">Edinburgh</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-73636"><name><surname>Zaidi</surname><given-names>Mone</given-names></name><role>Reviewing editor</role><aff><institution>Icahn School of Medicine at Mount Sinai</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>anton.bespalov@paasp.net</email> (AB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>24</day><month>05</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e63294</elocation-id><history><date date-type="received"><day>21</day><month>09</month><year>2020</year></date><date date-type="accepted"><day>20</day><month>05</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Bespalov et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Bespalov et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-63294-v1.pdf"/><abstract><p>While high risk of failure is an inherent part of developing innovative therapies, it can be reduced by adherence to evidence-based rigorous research practices. Numerous analyses conducted to date have clearly identified measures that need to be taken to improve research rigor. Supported through the European Union's Innovative Medicines Initiative, the EQIPD consortium has developed a novel preclinical research quality system that can be applied in both public and private sectors and is free for anyone to use. The EQIPD Quality System was designed to be suited to boost innovation by ensuring the generation of robust and reliable preclinical data while being lean, effective and not becoming a burden that could negatively impact the freedom to explore scientific questions. EQIPD defines research quality as the extent to which research data are fit for their intended use. Fitness, in this context, is defined by the stakeholders, who are the scientists directly involved in the research, but also their funders, sponsors, publishers, research tool manufacturers and collaboration partners such as peers in a multi-site research project. The essence of the EQIPD Quality System is the set of 18 core requirements that can be addressed flexibly, according to user-specific needs and following a user-defined trajectory. The EQIPD Quality System proposes guidance on expectations for quality-related measures, defines criteria for adequate processes (i.e., performance standards) and provides examples of how such measures can be developed and implemented. However, it does not prescribe any pre-determined solutions. EQIPD has also developed tools (for optional use) to support users in implementing the system and assessment services for those research units that successfully implement the quality system and seek formal accreditation. Building upon the feedback from users and continuous improvement, a sustainable EQIPD Quality System will ultimately serve the entire community of scientists conducting non-regulated preclinical research, by helping them generate reliable data that are fit for their intended use.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100010767</institution-id><institution>Innovative Medicines Initiative</institution></institution-wrap></funding-source><award-id>777364</award-id><principal-award-recipient><name><surname>MacLeod</surname><given-names>Malcolm R</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Anton Bespalov, AB is an employee and/or shareholder at PAASP GmbH, PAASP US LLC, Exciva GmbH, Synventa LLC, Ritec Pharma.</p></fn><fn fn-type="conflict" id="conf3"><p>Anja Gilis, AG are employees of Janssen / Johnson &amp; Johnson and shareholders at Johnson &amp; Johnson.</p></fn><fn fn-type="conflict" id="conf4"><p>Björn Gerlach, BG and CE are employees and shareholders at PAASP GmbH..</p></fn><fn fn-type="conflict" id="conf5"><p>Javier Guillen, JG is an employee of AAALAC International that is an EQIPD Associated Collaborator..</p></fn><fn fn-type="conflict" id="conf6"><p>Vincent Castagne, VC and CFC are employees of Porsolt..</p></fn><fn fn-type="conflict" id="conf7"><p>Isabel Lefevre, IAL and FD are employees of Sanofi..</p></fn><fn fn-type="conflict" id="conf8"><p>Fiona Ducrey, IAL and FD are employees of Sanofi..</p></fn><fn fn-type="conflict" id="conf9"><p>Lee Monk, LM is an employee and shareholder of UCB..</p></fn><fn fn-type="conflict" id="conf10"><p>Sandrine Bongiovanni, SB is an employee of Novartis Pharma..</p></fn><fn fn-type="conflict" id="conf11"><p>Bruce Altevogt, BA is an employee and shareholder of Pfizer. The views and opinions expressed in this article are those of the individual author and should not be attributed to Pfizer, its directors, officers, employees, affiliates, or any organization with which the author is employed or affiliated..</p></fn><fn fn-type="conflict" id="conf12"><p>Christoph H Emmerich, BG and CE are employees and shareholders at PAASP GmbH..</p></fn><fn fn-type="conflict" id="conf13"><p>Chantelle Ferland-Beckham, AB, BA, NdB, UD, CFB, PK, MK, MM, PM, PP, GR, JS, and TS are members of the Preclinical Data Forum (co-chairs - AB and TS), a network financially and organizationally supported by ECNP and Cohen Veterans Bioscience..</p></fn><fn fn-type="conflict" id="conf14"><p>Christelle Froger-Colléaux, VC and CFC are employees of Porsolt..</p></fn><fn fn-type="conflict" id="conf15"><p>Patricia Kabitzke, PK is an employee and shareholder at PAASP US LLC..</p></fn><fn fn-type="conflict" id="conf16"><p>Claudia Kurreck, UD and CK receive funding from Volkswagen Foundation.</p></fn><fn fn-type="conflict" id="conf17"><p>Paul Moser, PM is owner of Cerbascience Consulting.</p></fn><fn fn-type="conflict" id="conf18"><p>Heidrun Potschka, HP has received during the last three years consulting and speaking fees and/or funding for collaborative projects from Bayer, Roche, Zogenix, and Eisai..</p></fn><fn fn-type="conflict" id="conf19"><p>Kathleen Wuyts, KW is a consultant of Avertim, Brussels, Belgium, support for this contribution was funded by Janssen Pharmaceutica NV..</p></fn><fn fn-type="conflict" id="conf20"><p>Malcolm R MacLeod, MM, UD and TS are members of the Advisory Board at PAASP. MM, UD and TS are members of the ARRIVE guidelines working group..</p></fn><fn fn-type="conflict" id="conf21"><p>Ulrich Dirnagl, UD and CK receive funding from Volkswagen Foundation.MM, UD and TS are members of the Advisory Board at PAASP. MM, UD and TS are members of the ARRIVE guidelines working group..</p></fn><fn fn-type="conflict" id="conf22"><p>Thomas Steckler, MM, UD and TS are members of the Advisory Board at PAASP. MM, UD and TS are members of the ARRIVE guidelines working group.TS is an AAALAC ad-hoc specialist. TS and AG are employees of Janssen / Johnson &amp; Johnson and shareholders at Johnson &amp; Johnson..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>We have not generated any data</p></sec><supplementary-material><ext-link xlink:href="elife-63294-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>